| Drug–drug interactions can impact the efficacy of oral contraceptives. |
| Migraine predominately affects women of childbearing age; thus, it is important to identify potential drug–drug interactions between novel migraine therapies and commonly used contraceptives. |
| Erenumab does not affect the pharmacokinetics of a combination oral contraceptive containing ethinyl estradiol and norgestimate. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.